You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent hepatocellular carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Potential Chemoprevention Drugs in Recurrent Hepatocellular

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Surgery
  • No intervention for research purpose
  • Taichung, Taiwan
    China Medical University Hospital, Department of Surgery
Aug 5, 2023

Hepatocellular Carcinoma Trial in United States (AZD5851)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AZD5851
  • Duarte, California
  • +9 more
Oct 12, 2023

Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer Trial in Changsha (Microwave ablation, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Changsha, Hunan, China
    Hunan Provincial People's Hospital
Jul 8, 2022

Recurrent Hepatocellular Cancer, Chronic Liver Disease and Cirrhosis Trial in Seoul (Radiofrequency ablation using combined

Recruiting
  • Recurrent Hepatocellular Cancer
  • Chronic Liver Disease and Cirrhosis
  • Radiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodes
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 10, 2022

Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

Recruiting
  • Recurrent Hepatocellular Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 16, 2022

Carcinoma; Hepatocellular Trial (Stereotactic body radiation therapy)

Not yet recruiting
  • Carcinoma; Hepatocellular
  • Stereotactic body radiation therapy
  • (no location specified)
Oct 26, 2022

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Hepatocellular Carcinoma, Local Recurrence of Malignant Tumor of Liver Trial in Seoul (Radiofrequency ablation using combined

Active, not recruiting
  • Hepatocellular Carcinoma
  • Local Recurrence of Malignant Tumor of Liver
  • Radiofrequency ablation using combined bipolar and monopolar energy deliver with Twin Cooled-Wet electrodes
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 4, 2022

Detect and Expunge Concealed Tumors of the Liver

Recruiting
  • Liver Cancer
    • Hanoi, Vietnam
      108 Military Central Hospital
    Nov 15, 2023

    Hepatocellular Carcinoma Recurrent Trial in Chongqing (Tislelizumab/Sintilimab+Lenvatinib/Bevacizumab, RFA)

    Recruiting
    • Hepatocellular Carcinoma Recurrent
    • Chongqing, Chongqing, China
      Institute of hepatobiliary surgery,Southwest Hospital
    Mar 11, 2022

    Post-orthotopic Liver Transplantation, Hepatocellular Carcinoma Recurrent Trial in Nanjing (Bevacizumab Biosimilar IBI305)

    Not yet recruiting
    • Post-orthotopic Liver Transplantation
    • Hepatocellular Carcinoma Recurrent
    • Bevacizumab Biosimilar IBI305
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    May 5, 2022

    Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

    Active, not recruiting
    • Child-Pugh Class A
    • +2 more
    • Stereotactic Body Radiation Therapy
    • +3 more
    • Palo Alto, California
    • +1 more
    Sep 9, 2022

    BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

    Withdrawn
    • BCLC Stage B Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab
    • +3 more
    • (no location specified)
    Dec 12, 2022

    Recurrent Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8 Trial in

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • +3 more
    • Proton Stereotactic Body Radiation Therapy
    • Quality-of-Life Assessment
    • Scottsdale, Arizona
    • +1 more
    Jan 5, 2023

    Recurrent Hepatocellular Cancer Trial (toripalimab, Lenvatinib, Radiofrequency ablation)

    Not yet recruiting
    • Recurrent Hepatocellular Cancer
    • (no location specified)
    Jan 12, 2022

    Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Tislelizumab combined with Levatinib)

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Sun Yat-sen University
    Mar 31, 2022

    Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab and Bevacizumab Combined with Radiotherapy)

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • Sintilimab and Bevacizumab Combined with Radiotherapy
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Sun Yat-sen University
    Sep 2, 2021

    Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,

    Active, not recruiting
    • Recurrent Hepatocellular Carcinoma
    • +4 more
    • Scottsdale, Arizona
    • +2 more
    Oct 7, 2022

    Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

    Not yet recruiting
    • Liver Transplant; Complications
    • +3 more
    • multi-kinase inhibitors in combination with bevacizumab
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Sep 11, 2023

    Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

    Active, not recruiting
    • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
    • +27 more
    • Los Angeles, California
    • +2 more
    Aug 5, 2022

    Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent Trial in New York, Hong Kong, Singapore

    Recruiting
    • Hepatitis B Virus Related Hepatocellular Carcinoma
    • Hepatocellular Carcinoma Recurrent
    • SCG101
    • New York, New York
    • +4 more
    Nov 18, 2022

    Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

    Recruiting
    • Colorectal Carcinoma
    • +21 more
    • Dual X-ray Absorptiometry
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jan 30, 2023

    Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • San Antonio, Texas
      Next Oncology
    Aug 9, 2022

    Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Ablation)

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 21, 2021

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022